The functionalized liposomes reduced the tumor by twofold more when compared with unmodified liposomes, suggesting the potential of gemcitabine/HIF1α-siRNA-loaded GE-11-modified liposomes in pancreatic cancer treatment [102]. This evidence concerns the gene HIF1A and pancreatic neoplasm.